JP2024521401A5 - - Google Patents

Info

Publication number
JP2024521401A5
JP2024521401A5 JP2023575711A JP2023575711A JP2024521401A5 JP 2024521401 A5 JP2024521401 A5 JP 2024521401A5 JP 2023575711 A JP2023575711 A JP 2023575711A JP 2023575711 A JP2023575711 A JP 2023575711A JP 2024521401 A5 JP2024521401 A5 JP 2024521401A5
Authority
JP
Japan
Prior art keywords
transcription factor
mutant
vector
bhlh transcription
bhlh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575711A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521401A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050923 external-priority patent/WO2022256933A1/en
Publication of JP2024521401A publication Critical patent/JP2024521401A/ja
Publication of JP2024521401A5 publication Critical patent/JP2024521401A5/ja
Pending legal-status Critical Current

Links

JP2023575711A 2021-06-09 2022-06-09 神経細胞リプログラミングのための方法及び組成物 Pending JP2024521401A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163208627P 2021-06-09 2021-06-09
US63/208,627 2021-06-09
PCT/CA2022/050923 WO2022256933A1 (en) 2021-06-09 2022-06-09 Method and compositions for neuronal reprogramming

Publications (2)

Publication Number Publication Date
JP2024521401A JP2024521401A (ja) 2024-05-31
JP2024521401A5 true JP2024521401A5 (cg-RX-API-DMAC7.html) 2025-06-16

Family

ID=84424544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575711A Pending JP2024521401A (ja) 2021-06-09 2022-06-09 神経細胞リプログラミングのための方法及び組成物

Country Status (11)

Country Link
US (1) US20250282837A1 (cg-RX-API-DMAC7.html)
EP (1) EP4352085A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024521401A (cg-RX-API-DMAC7.html)
KR (1) KR20240032021A (cg-RX-API-DMAC7.html)
CN (1) CN117881692A (cg-RX-API-DMAC7.html)
AU (1) AU2022288230A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025888A2 (cg-RX-API-DMAC7.html)
CA (1) CA3222129A1 (cg-RX-API-DMAC7.html)
IL (1) IL309190A (cg-RX-API-DMAC7.html)
MX (1) MX2023014769A (cg-RX-API-DMAC7.html)
WO (1) WO2022256933A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220084391A (ko) * 2019-10-21 2022-06-21 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) 분기 형태들 합성
CN115670390B (zh) * 2022-12-30 2023-04-07 广东工业大学 一种帕金森病轴向症状严重程度表征方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037527A1 (en) * 2012-09-07 2014-03-13 Cambridge Enterprise Limited Maturation of mammalian cells by modulation of protein phosphorylation

Similar Documents

Publication Publication Date Title
JP2024521401A5 (cg-RX-API-DMAC7.html)
JP2023503455A5 (cg-RX-API-DMAC7.html)
JP2025507338A5 (cg-RX-API-DMAC7.html)
JP7291423B2 (ja) ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用
JP2008541759A5 (cg-RX-API-DMAC7.html)
CN114057858B (zh) 对引起神经变性和神经退行性疾病的蛋白聚集具有解聚作用的多肽
JP2022512579A5 (cg-RX-API-DMAC7.html)
JP2021525245A5 (cg-RX-API-DMAC7.html)
JP2022533451A5 (cg-RX-API-DMAC7.html)
RU2019136495A (ru) C-концевые фрагменты cdnf и маnf, фармацевтические композиции, содержащие указанные фрагменты, и применения указанных фрагментов и композиций
JP2021534206A5 (cg-RX-API-DMAC7.html)
Verma et al. Unraveling the potential of EphA4: a breakthrough target and beacon of hope for neurological diseases
JP2024523445A5 (cg-RX-API-DMAC7.html)
JP2021534206A (ja) Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置
FI3873511T3 (fi) Ekspressiovektori kolesteroli-24-hydrolaasille amyotroofisen lateraaliskleroosin hoitoon
JP2024515307A5 (cg-RX-API-DMAC7.html)
JP2024505197A5 (cg-RX-API-DMAC7.html)
JP2023509187A5 (cg-RX-API-DMAC7.html)
JP2023544141A (ja) ＡＩＭＰ２－ＤＸ２および必要に応じてｍｉＲ－１４２の標的配列ならびにその組成物を使用した神経系疾患を処置する方法
KR102565470B1 (ko) 아밀로이드 베타 특이적 펩타이드 sma_04088-2 및 이를 포함하는 알츠하이머병 치료용 조성물
KR102565471B1 (ko) 아밀로이드 베타 특이적 펩타이드 cbrv1-04369 및 이를 포함하는 알츠하이머병 치료용 조성물
JP2025508429A5 (cg-RX-API-DMAC7.html)
JP2025512061A5 (cg-RX-API-DMAC7.html)
JP2023505271A5 (cg-RX-API-DMAC7.html)
JP2024534901A5 (cg-RX-API-DMAC7.html)